Patients with a history of the following within =<  months of study entry are not eligible:\r\n* Arterial thromboembolic events\r\n* Unstable angina\r\n* Myocardial Infarction
No angina or myocardial infarction within  days of registration; in view of potential cardiac risk with lenalidomide, patients with stable angina will be excluded
History of myocardial infarction or unstable angina within  months prior to day 
Unstable angina or myocardial infarction.
Must not have a history of myocardial infarction, severe or unstable angina, peripheral vascular disease or familial QT prolongation
Myocardial infarction of unstable angina within  months prior to the planned start date of study drug.
Any comorbidity or condition which, in the opinion of the investigator, may interfere with the assessments and procedures of this protocol e.g. unstable angina, myocardial infarction within  months, severe infection, etc.
Myocardial infarction or unstable angina within  months of the first date of treatment on this study.
History of cerebral vascular accident, unstable angina, myocardial infarction, or ventricular arrhythmia within the last  months
Having known myocardial infarction or unstable angina within  months before first ZW dosing
History of myocardial infarction or unstable angina within  months of registration
History of myocardial infarction or unstable angina within  months prior to day 
Has a history of myocardial infarction or unstable angina within  months before enrollment
Patients with unstable angina and/or myocardial infarction within  months prior to screening
History of myocardial infarction or unstable angina within  months prior to first study treatment
Unstable angina or a history of myocardial ischemia within prior  months
History of myocardial infarction or unstable angina within  months prior to cycle , day 
Myocardial infarction or unstable angina within  months of enrollment
Arterial ischemic event (e.g., unstable angina, myocardial infarction, stroke) within  months of study entry
Myocardial infarction within the past  months, or stable or unstable angina
History of myocardial infarction or severe unstable angina
Patients with a history of myocardial infarction, unstable angina, or uncontrolled arrhythmia within  months from enrollment.
ST elevation myocardial infarction within  days prior to enrollment; unstable angina or significant, untreated arrhythmias within  days prior to enrollment
History of myocardial infarction or unstable angina within  months prior to study enrollment
History of myocardial infarction or unstable angina within the past  months
History of myocardial infarction or unstable angina within  months prior to day 
Patients with a myocardial infarction or unstable angina within  months of study entry
Unstable angina or a history of myocardial ischemia within prior  months
Myocardial infarction or uncontrolled angina within  months
History of a stroke, myocardial infarction, or unstable angina in the previous  months
Has a medical history of myocardial infarction or unstable angina
History of myocardial infarction within  months or unstable angina within the past  months.
Myocardial infarction or unstable angina less than  months before registration
History of myocardial infarction or unstable angina within  months prior to Day 
Must not have a history of myocardial infarction, severe or unstable angina, or peripheral vascular disease
Myocardial infarction or unstable angina <  months prior to registration
History of myocardial infarction or unstable angina within  months prior to study enrollment
history within the last  months of symptomatic congestive heart failure, myocardial infarction, or unstable angina
Unstable angina and/or myocardial infarction within  months prior to screening
History of myocardial infarction (within  months) or unstable angina (within  months) prior to study enrolment.
Patients are excluded if they have a history of myocardial infarction or unstable angina within  months prior to randomization
History of myocardial infarction, severe/unstable angina, or symptomatic congestive heart failure, within the  months prior to study drug administration
Unstable angina or new-onset angina (begun within the last  months), or myocardial infarction within the  months prior to enrollment
Myocardial infarction or unstable angina within  months prior to registration.
Diagnosis of unstable angina or myocardial infarction within  months of study entry
Patients with a history of stroke, myocardial infarction, or unstable angina within  months prior to registration are not eligible
Myocardial infarction or unstable angina within  months prior to Day  of the study.
Myocardial infarction or unstable angina within  months prior to the first dose of study drug.
Recent history of myocardial infarct (less than  months) or history of active angina or arrhythmia
Patients with a history of the following within =<  months of study entry are not eligible:\r\n* Arterial thromboembolic events\r\n* Unstable angina\r\n* Myocardial Infarction
History of myocardial infarction or unstable angina within  months prior to study Day
History of myocardial infarction or unstable angina within  months prior to day 
History of myocardial infarction or unstable angina within  months prior to day -
Patients with myocardial infarction or unstable angina =<  months prior to registration
History of myocardial infarction or unstable angina within  months prior to day 
History of myocardial infarction or unstable angina within  months prior to enrollment.
Myocardial infarction or uncontrolled angina within  months;
History of myocardial infarction or unstable angina within  months prior to Day 
Active coronary artery disease, unstable or newly diagnosed angina or myocardial infarction less than  months prior to first study drug administration
Has a medical history of myocardial infarction or unstable angina.
History of myocardial infarction or unstable angina within  months prior to first study treatment
unstable angina or myocardial infarction within  months of enrollment.
Myocardial infarction or unstable angina <  months prior to enrollment
History of unstable angina or myocardial infarction within  months prior to Day  or ischemic heart disease.
Myocardial infarction, severe angina, or unstable angina within  months prior to administration of first dose of study drug
History of myocardial infarction within  months prior to Cycle , Day , or history of unstable angina
History of myocardial infarction or unstable angina within  months of enrollment
Unstable angina or myocardial infarction within  months prior to first dose
History of myocardial infarction, severe or unstable angina, peripheral vascular disease or familial QTc prolongation.
History of myocardial infarction or uncontrolled angina within  months prior to administration of study drug
Myocardial infarction or unstable angina within  months prior to the first administration of study drug;
Unstable angina or myocardial infarction within  months of enrolment,
History of myocardial infarction within  months before Cycle , Day , or history of unstable angina
Myocardial infarction or unstable angina within  months of day  prior to registration
Significant cardiovascular diseases (i.e., hypertension not controlled by medical therapy, unstable angina, history of myocardial infarction within the past  months,
History of a stroke, myocardial infarction, or unstable angina in the previous  months
History of myocardial infarction or unstable angina within  months prior to day 
Myocardial infarction or unstable angina within  or  month of starting nintedanib treatment, respectively
History of unstable angina or myocardial infarction in the last week
History of unstable angina or myocardial infarction  month prior to study enrollment
History of myocardial infarction or unstable angina within  months prior to day 
No unstable angina, regular use of nitroglycerin for exertional angina, or myocardial infarction (MI) within the last  months
History of unstable angina or myocardial infarction  month prior to study enrollment
History of unstable angina or myocardial infarction  month prior to study enrollment
Patients with myocardial infarction or unstable angina <  months prior to starting study
